Behringwerke AG, a subsidiary of Sanofi, is a German company located in Marburg. The firm produces specialty chemicals and pharmaceutical products.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Alpha Therapeutic Corp., a subsidiary of Grifols SA /Grifols Family/, is an American company located in Los Angeles, CA. The firm develops of plasma derived products.

Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions

Shandong Taibang Biological Products Co. Ltd., part of China Biologic Products Holdings, Inc., is a Chinese company located in Tai'an that manufactures and wholesales biological products. The firm was founded in 2002. Guang Li Pang has been the CEO since the company founding.

LFB USA, Inc. is an American company located in Framingham, MA and ultimately controlled by the Government of France. The firm manufactures and markets medicinal products. Jose Antonio Moreno Toscano is the CEO, in this role since 2018.

Guizhou Taibang Biological Products Co., Ltd. engages in research, development, production and sale of blood products and biochemical drugs. Its products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin, hepatitis B human immunoglobulin, rabies immune globulin, tetanus human immunoglobulin, human prothrombin complex, and placental polypeptide injection. The company was founded on May 21, 1996 and is head quartered in Guiyang, China.

Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura, Itsuzo Hata, and Naokichi Kaneko on June 17, 1918 and is headquartered in Osaka, Japan.

Qingdao Senmiao Industrial Co., Ltd., established on 2000-11-28, Business scope includes food production,Sales,Functional protein development,develop,Sales(The above-mentioned business activities are carried out in accordance with the license issued by the Food and Drug Administration),Biotechnology R&D,Technology Promotion,Economic Information Consulting Service(Does not include finance,securities,futures),Import and export of goods and technology(Except for items prohibited by laws and administrative regulations,Projects restricted by laws and administrative regulations will be operated after obtaining permission),Conference Services,Sales:Chemical Products(Does not contain dangerous goods),fresh meat,feed,cosmetic,hygiene products,Daily necessities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Qingdao Senmiao Biotechnology Co., Ltd., established on 2003-07-23, Business scope includes biotechnology product development,develop,Sales(Does not contain food,Health products,Does not contain country-restricted items);Sell ​​Home Appliances,Daily necessities,hardware,Chemical Products(Free of Hazardous Chemicals),building decoration materials(No paint);dairy goat farming(Limited to branch operations). (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Anyuan Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese private company located in Shanghai. The firm develops biological macromolecular drugs. It was founded in 2016. Qiang Li is currently the CEO of the company.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Part of Sekisui Chemical Co., Ltd., Sekisui Medical Co., Ltd. is a Japanese company located in Tokyo that manufactures and markets in-vitro diagnostic substances and pharmaceutical products. It was acquired by Sekisui Chemical Co., Ltd. from Daiichi Sankyo Co., Ltd. on October 02, 2006.

Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd. is a Chinese private company located in Chengdu. The firm manufactures pharmaceuticals.